Elanco Animal Health Incorporated
ELAN
$24.88
-$1.21-4.64%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -711.76% | -409.09% | -83.58% | 937.50% | -102.20% |
| Total Depreciation and Amortization | 0.00% | 4.35% | 5.92% | -1.30% | -3.75% |
| Total Amortization of Deferred Charges | -25.00% | 0.00% | -11.11% | -10.00% | 0.00% |
| Total Other Non-Cash Items | -183.33% | 260.00% | 0.00% | 114.29% | 94.35% |
| Change in Net Operating Assets | 281.36% | 13.46% | 121.94% | -523.21% | -77.42% |
| Cash from Operations | -50.68% | -7.59% | 6,025.00% | -102.26% | 9.26% |
| Capital Expenditure | 32.61% | -61.40% | 12.31% | -38.30% | -11.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -100.00% | -- | -100.00% |
| Other Investing Activities | 77.78% | -1,000.00% | 150.00% | 0.00% | 75.00% |
| Cash from Investing | 36.63% | -80.36% | 3.45% | 35.56% | -107.23% |
| Total Debt Issued | 526.21% | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | -1,020.74% | 57.85% | -150.56% | -368.42% | 97.74% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 207.06% | -187.93% | 1,550.00% | -433.33% | 175.00% |
| Cash from Financing | 88.24% | 1.92% | -400.00% | 262.50% | 97.61% |
| Foreign Exchange rate Adjustments | 1,300.00% | -96.30% | -6.90% | 137.66% | -1,062.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 217.65% | -165.38% | 173.68% | 186.36% | -129.73% |